AAAAAA

   
Results: 1-16 |
Results: 16
PERSPECTIVES ON ADOPTIVE OR VACCINAL CELL IMMUNOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA
Authors: BUZYN A OSTANKOVITCH M VARET B GUILLET JG
Citation: A. Buzyn et al., PERSPECTIVES ON ADOPTIVE OR VACCINAL CELL IMMUNOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA, HEM CELL TH, 40(5), 1998, pp. 222-223
THE FEASIBILITY OF PERIPHERAL-BLOOD STEM-CELL COLLECTION FOR AUTOGRAFT FOLLOWING FAILURE IN BONE-MARROW ASPIRATION
Authors: LEFRERE F HERMINE O AUDAT F BUZYN A CAVAZZANACALVO M BOCCACCIO C VARET B
Citation: F. Lefrere et al., THE FEASIBILITY OF PERIPHERAL-BLOOD STEM-CELL COLLECTION FOR AUTOGRAFT FOLLOWING FAILURE IN BONE-MARROW ASPIRATION, HEM CELL TH, 40(3), 1998, pp. 133-137
IMMUNOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA - DIFFERENT APPROACHES TOWARDS IDENTIFICATION OF A LEUKEMIA ASSOCIATED ANTIGEN
Authors: BUZYN A OSTANKOVITCH M KEMULA M CONNAN F AUDAT F VARET B GUILLET JG CHOPPIN J
Citation: A. Buzyn et al., IMMUNOTHERAPY FOR CHRONIC MYELOID-LEUKEMIA - DIFFERENT APPROACHES TOWARDS IDENTIFICATION OF A LEUKEMIA ASSOCIATED ANTIGEN, HEM CELL TH, 40(2), 1998, pp. 86-86
CELL-MEDIATED ANTITUMOR IMMUNITY AND IMPL ICATIONS FOR IMMUNOTHERAPY
Authors: GUILLET JG BUZYN A LEGAL FA OSTANKOVITCH M
Citation: Jg. Guillet et al., CELL-MEDIATED ANTITUMOR IMMUNITY AND IMPL ICATIONS FOR IMMUNOTHERAPY, HEM CELL TH, 40(2), 1998, pp. 92-95
CML PATIENT IN HEMATOLOGIC REMISSION CAN MOUNT A CYTOTOXIC T-CELL RESPONSE IN-VITRO AGAINST THE NATURAL PEPTIDES ELUTED FROM HIS CML CELLS
Authors: BUZYN A KEMULA M CONNAN F AUDAT F VARET B CHOPPIN J GUILLET JG OSTANKOVITCH M
Citation: A. Buzyn et al., CML PATIENT IN HEMATOLOGIC REMISSION CAN MOUNT A CYTOTOXIC T-CELL RESPONSE IN-VITRO AGAINST THE NATURAL PEPTIDES ELUTED FROM HIS CML CELLS, Bone marrow transplantation, 21, 1998, pp. 229-229
USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC TRANSPLANTATION
Authors: BOCCACCIO C BEAUJEAN F KUENTZ M RIO B BELANGER C BUZYN A SUTTON L LEBLOND V VERNANT JP
Citation: C. Boccaccio et al., USE OF CRYOPRESERVED BONE-MARROW IN ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 324-324
QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY
Authors: WATTEL E SOLARY E HECQUET B CAILLOT D IFRAH N BRION A MAHE B MILPIED N JANVIER M GUERCI A ROCHANT H CORDONNIER C DREYFUS F BUZYN A HOANGNGOC L STOPPA AM GRATECOS N SADOUN A STAMATOULAS A TILLY H BRICE P MALOISEL F LIOURE B DESABLENS B PIGNON B ABGRALL JP LEPORRIER M DUPRIEZ B GUYOTAT D LEPELLEY P FENAUX P
Citation: E. Wattel et al., QUININE IMPROVES THE RESULTS OF INTENSIVE CHEMOTHERAPY IN MYELODYSPLASTIC SYNDROMES EXPRESSING P-GLYCOPROTEIN - RESULTS OF A RANDOMIZED STUDY, British Journal of Haematology, 102(4), 1998, pp. 1015-1024
ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY TIMED SEQUENTIAL CHEMOTHERAPY (EMA) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Authors: THOMAS X CORDONNIER C DOMBRET H FEGUEUX N MALOISEL F VEKHOFF A REMAN O VILQUE JP GRATECOS N DEREVEL T COASIN T BUZYN A CAHN JY GUERCI A CHOMIENNE C ARCHIMBAUD E DEGOS L FENAUX P
Citation: X. Thomas et al., ALL-TRANS-RETINOIC ACID (ATRA) FOLLOWED BY TIMED SEQUENTIAL CHEMOTHERAPY (EMA) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (APBSCT) IN RELAPSED ACUTE PROMYELOCYTIC LEUKEMIA (APL), British Journal of Haematology, 102(1), 1998, pp. 150-150
INTENSIVE THERAPY IN 100 PATIENTS WITH PH1 AND OR BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FIRST INTERIM ANALYSIS OF THE FRENCH-BELGIAN-AUSTRALIAN LALA-94 TRIAL/
Authors: DOMBRET H THOMAS X BLAISE D HUGUET F BOIRON JM BUZYN A STAMATOULAS A DELANNOY A BRADSTOCK K BOUCHEIX C CHARRIN C GABERT J LEBBE G LHERITIER V FIERE D
Citation: H. Dombret et al., INTENSIVE THERAPY IN 100 PATIENTS WITH PH1 AND OR BCR-ABL POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - FIRST INTERIM ANALYSIS OF THE FRENCH-BELGIAN-AUSTRALIAN LALA-94 TRIAL/, British Journal of Haematology, 102(1), 1998, pp. 270-270
ANTILEUKEMIC HLA-RESTRICTED T-CELL CLONES GENERATED WITH NATURALLY PROCESSED PEPTIDES ELUTED FROM ACUTE MYELOBLASTIC-LEUKEMIA BLASTS
Authors: OSTANKOVITCH M BUZYN A BONHOMME D CONNAN F BOUSCARY D HESHMATI F DREYFUS F CHOPPIN J GUILLET JG
Citation: M. Ostankovitch et al., ANTILEUKEMIC HLA-RESTRICTED T-CELL CLONES GENERATED WITH NATURALLY PROCESSED PEPTIDES ELUTED FROM ACUTE MYELOBLASTIC-LEUKEMIA BLASTS, Blood, 92(1), 1998, pp. 19-24
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA
Authors: GUARDIOLA P ESPEROU H CAZALS D IFRAH N JOUET JP BUZYN A SUTTON L GRATECOS N TILLY H LIOURE B GLUCKMAN E
Citation: P. Guardiola et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA, Experimental hematology, 25(8), 1997, pp. 202-202
PEPTIDES DERIVED FROM THE WHOLE SEQUENCE OF BCR-ABL, BIND TO SEVERAL CLASS-I MOLECULES ALLOWING SPECIFIC INDUCTION OF HUMAN CYTOTOXIC T-LYMPHOCYTES
Authors: BUZYN A OSTANKOVITCH M ZERBIB A KEMULA M CONNAN F VARET B GUILLET JG CHOPPIN J
Citation: A. Buzyn et al., PEPTIDES DERIVED FROM THE WHOLE SEQUENCE OF BCR-ABL, BIND TO SEVERAL CLASS-I MOLECULES ALLOWING SPECIFIC INDUCTION OF HUMAN CYTOTOXIC T-LYMPHOCYTES, European Journal of Immunology, 27(8), 1997, pp. 2066-2072
IL-7 SENSITIZES HUMAN PRE-B CELLS BUT NOT PRO-B CELLS TO FAS APO-1 (CD95)-MEDIATED APOPTOSIS/
Authors: LEVY Y BENLAGHA K BUZYN A COLOMBE M BROUET JC LASSOUED K
Citation: Y. Levy et al., IL-7 SENSITIZES HUMAN PRE-B CELLS BUT NOT PRO-B CELLS TO FAS APO-1 (CD95)-MEDIATED APOPTOSIS/, Clinical and experimental immunology, 110(2), 1997, pp. 329-335
ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA
Authors: GUARDIOLA P ESPEROU H CAZALSHATEM D IFRAH N JOUET JP BUZYN A SUTTON L GRATECOS N TILLY H LIOURE B GLUCKMAN E
Citation: P. Guardiola et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR AGNOGENIC MYELOID METAPLASIA, British Journal of Haematology, 98(4), 1997, pp. 1004-1009
CML PATIENT IN HEMATOLOGIC REMISSION CAN MOUNT A CYTOTOXIC T-CELL RESPONSE IN-VITRO AGAINST THE NATURAL PEPTIDES ELUTED FROM HIS CML CELLS
Authors: BUZYN A OSTANKOVITCH M KEMULA M CONNAN F AUDAT F VARET B GUILLET JG CHOPPIN J
Citation: A. Buzyn et al., CML PATIENT IN HEMATOLOGIC REMISSION CAN MOUNT A CYTOTOXIC T-CELL RESPONSE IN-VITRO AGAINST THE NATURAL PEPTIDES ELUTED FROM HIS CML CELLS, Blood, 90(10), 1997, pp. 3985-3985
NATURALLY PROCESSED PEPTIDES ELUTED FROM ACUTE MYELOBLASTIC-LEUKEMIA BLASTS COULD PRIME AN HLA-RESTRICTED ANTITUMOR RESPONSE
Authors: OSTANKOVITCH M BUZYN A CONNAN F CHOPPIN J BOUSCARY D DREYFUS F GUILLET JG
Citation: M. Ostankovitch et al., NATURALLY PROCESSED PEPTIDES ELUTED FROM ACUTE MYELOBLASTIC-LEUKEMIA BLASTS COULD PRIME AN HLA-RESTRICTED ANTITUMOR RESPONSE, Blood, 90(10), 1997, pp. 2385-2385
Risultati: 1-16 |